EP 2209768 A1 20100728 - 5,6-DIARYL PYRIDINES SUBSTITUTED IN THE 2- AND 3-POSITION, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
Title (en)
5,6-DIARYL PYRIDINES SUBSTITUTED IN THE 2- AND 3-POSITION, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
Title (de)
IN DER 2ER- UND 3ER-POSITION SUBSTITUIERTE 5,6-DIARYLPYRIDINE, IHRE HERSTELLUNG UND IHRE THERAPEUTISCHE VERWENDUNG
Title (fr)
5,6-DIARYLES PYRIDINES SUBSTITUES EN POSITION 2 ET 3, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
Publication
Application
Priority
- FR 2008001421 W 20081010
- FR 0707186 A 20071012
Abstract (en)
[origin: TW200922567A] The invention relates to compounds of formula (I): in which: Q represents an oxygen atom, a sulfur atom or a radical -NR1- Z represents a group -N(R3)XR4, -N(R3)COOR5 or -OCON(R3)R5 where X represents a group -CO-, -SO2-, -CON(R6)- or -CSN(R6)-; Y represents a group -R1', -OR5' -N(R3')X'R4', -N(R3')COOR5', -NR7'R8', CON(R3')R5', -CSN(R3')R5', -C(O)R2', -C(O)-O-R2', -SO2R2', -SO2N(R3')R5 or -OCON(R3')R5' where X' represents a group -CO-, -SO2-, -CON(R6')- or - CSN(R6')-; Ar1 and Ar2 represent, independently of each other, an unsubstituted or substituted phenyl; k represents 0 or 1; m represents 0 or 1; and Alk' represents (C1-C7)alkyl group; in the form of base or of acid- addition salt.
IPC 8 full level
C07D 213/38 (2006.01); A61K 31/4418 (2006.01); A61P 1/00 (2006.01); A61P 3/00 (2006.01); A61P 25/00 (2006.01); A61P 29/00 (2006.01); A61P 37/00 (2006.01); C07D 213/40 (2006.01); C07D 213/42 (2006.01); C07D 213/64 (2006.01)
CPC (source: EP US)
A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 1/08 (2017.12 - EP); A61P 1/12 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 3/00 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/06 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 19/00 (2017.12 - EP); A61P 19/08 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); C07D 213/38 (2013.01 - EP US); C07D 213/40 (2013.01 - EP US); C07D 213/42 (2013.01 - EP US); C07D 213/64 (2013.01 - EP US)
Citation (search report)
See references of WO 2009087285A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
FR 2922209 A1 20090417; FR 2922209 B1 20100611; AR 068778 A1 20091202; AU 2008346293 A1 20090716; BR PI0818061 A2 20150331; CA 2702012 A1 20090716; CL 2008003027 A1 20091016; CN 101855208 A 20101006; EA 201070460 A1 20101029; EP 2209768 A1 20100728; IL 205016 A0 20101130; JP 2011500543 A 20110106; JP 5465179 B2 20140409; KR 20100065377 A 20100616; MA 31839 B1 20101101; MX 2010003983 A 20100527; PA 8798201 A1 20090515; PE 20091034 A1 20090819; TW 200922567 A 20090601; US 2010256202 A1 20101007; US 8362045 B2 20130129; UY 31387 A1 20090529; WO 2009087285 A1 20090716; WO 2009087285 A4 20090924
DOCDB simple family (application)
FR 0707186 A 20071012; AR P080104435 A 20081010; AU 2008346293 A 20081010; BR PI0818061 A 20081010; CA 2702012 A 20081010; CL 2008003027 A 20081010; CN 200880115604 A 20081010; EA 201070460 A 20081010; EP 08869799 A 20081010; FR 2008001421 W 20081010; IL 20501610 A 20100411; JP 2010528446 A 20081010; KR 20107007838 A 20081010; MA 32824 A 20100510; MX 2010003983 A 20081010; PA 8798201 A 20081009; PE 2008001755 A 20081010; TW 97139016 A 20081009; US 75588310 A 20100407; UY 31387 A 20081010